Business Services

Pharmaceutical Business Services – News, analysis and company profiles

Showing 15 posts of 2453 posts found.

FDA fast track oral treatment of dermatitis

November 4, 2021 Business Services

UNION therapeutics have received a Fast Track designation from the FDA for their oral orismilast for the treatment of moderate …

HPV vaccine cutting cervical cancer rates by 87%

November 4, 2021 Business Services

The human papillomavirus (HPV) vaccine is cutting cervical cancer rates by 87% in women who were offered the vaccine between …
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …

Angel Pharmaceuticals receives IND approval for Phase 1/1b Inhibitor in China

October 28, 2021 Business Services

Angel Pharmaceuticals has received approval for their IND application, from the Center for Drug Evaluation (CDE) of the China National …
credit_-_crevis_shutterstock_340710245_720

Serial radiation therapy safe as alternative treatment for kidney cancer

October 28, 2021 Business Services

The University of Texas MD Anderson Cancer Center has reported that Serial radiation therapy as monotherapy is a safe and …

First long-acting HIV-treatment to be distributed in European countries

October 28, 2021 Business Services

ViiV Healthcare, the global specialist HIV company, have presented positive interim data showing Vocabria (cabotegravir) and Rekambys (rilpivirine), the first …

FDA approves Phase II clinical trial of combination treatment for COVID-19

October 28, 2021 Business Services

The FDA has approved Vitti Labs’ Investigational New Drug (IND) application to conduct Phase II Clinical Trials using a combination …

‘Plan C’ COVID response is urgent, doctors say

October 21, 2021 Business Services

UK Ministers are considering the implementation of a COVID ‘Plan C’. Cabinet Office officials are said to be discussing proposals …
mat-napo-pij34zrzeew-unsplash

Open Orphan to conduct first-ever COVID-19 human challenge trial

October 21, 2021 Business Services

Open Orphan has announced that they are progressing with their government-backed COVID-19 vaccine human challenge study. The company has signed …

Novartis extend COVID-19 vaccine deal with BioNTech

October 21, 2021 Business Services

Novartis announced today that it has signed an initial agreement with BioNTech SE to expand its support of the fill-and-finish …

Small Pharma’s Phase IIa DMT-assisted therapy begins

October 21, 2021 Business Services

Small Pharma has announced that the first patient has been dosed in the company’s Phase IIa clinical trial for its …
The Gateway to Local Adoption Series

Latest content